GI: IBS and IBD Drugs Flashcards

1
Q

Lubriprostone (amitiza)

  • class
  • MOA
  • indication
  • OOA
  • SE
  • drug-drug interactions
A

Secretory Agent (chloride chanel activator)

MOA: activates Cl- channels–>increases fluid secretion in the intestinal lumen–>eases passage of stool with LITTLE electrolyte change
*increases weekly BMs

IND:

  • IBS-C
  • chronic constipation

OOA: 24 hours

SE:

  • N/V
  • dyspepsia
  • HA
  • dizziness
  • hypotension

*Very little drug-drug interactions bc drug is quickly absorbed in stomach + jejunum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Linaclotide (Linzess)

  • class
  • MOA
  • indication
  • SE
  • do not use in?
A

Secretory Agent

MOA:
peptide agonist of cyclic GMP–>enhancing Cl- and HCO3- secretion into the lumen–>incrs water secretion–>increasing motility

IND:
*IBS-C

SE: 
*diarrhea 
*abdmon pain 
*flatulence 
*HA 
*abdominal distention 
DO NOT USE in PT <17 YO
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

IBS vs IBD

A

irritable bowel syndrome vs inflammatory bowel disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

list the drug classes to tx IBD

A
  • 5-aminosalicylates
  • Corticosteroids
  • Biologic Agents–TNF-alpha inhibitors, Alpha-4 integrin inhibitors, IL-12/23 inhibitor
  • Immunomodulators
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MOA of 5-aminosalicylates

A
  1. exact MOA unknown
  2. anti-inflammatory + immunosuppressive properties effects via multiple mechanisms
    - ->inhibition of cytokine synthesis
    - ->inhibition of leukotriene and prostaglandin synthesis
    - ->scavenging of free radicals
    - ->inhibition of T-cell proliferation, activation and differentiation
    - ->impairment of leukocyte adhesion and function
  3. act locally in intestine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the first line agent for UC

A

5-aminosalicylates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Distribution patterns of CD vs UC

A

UC: continuous involvement of colon–beginning w/ rectum.

CD: affect any portion of the GI tract from mouth–anus—noncontinuous fashion and is characterized by transmural inflammation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what layer does UC affect

A

limited to mucosal layer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the two compounds found in the 5-ASA agents

A

Azo and Mesalamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Sulfasalazine

  • class
  • chemical composition
  • MOA…. also works primarily where?
  • indications
  • SE
  • routes of admin
A
  • 5-ASA (azo compounds)
  • prodrug w/ 5-ASA linked to sulfapyridine

MOA:

  • 5-ASA linked to Sulfapyridine is cleaved by gut bacteria–> to produce 5-ASA aka Mesalamine + Sulfapyradine
    • works primarily in the colon
  • inhibits transport of reduced folic acid across cell membranes

Indications: UC–induction and maintenance of remission
have to give with folate**

SE:

  • Nausea
  • HA
  • fever
  • rash
  • RARE–life threatening agranulocytosis

PO route only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

which causes more SE: Sulfasalazine or Mesalamine

WHY

A

Sulfasalazine
because its composition is 5-ASA + Sulfapyridine— when the gut bacteria cleave the drug–>5-ASA and Sulfapyridine

Sulfapyradine is the reason for the SE

Mesalamine is unliked 5-ASA so it has less SE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

which drug can cause agranulocytosis

A

Sulfasalazine

used in tx for IBD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

which drug do you need to give with folate

A

Sulfasalazine—- 5-ASA for IBD
and
methotrexate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mesalamine

  • class
  • chemical composition
  • MOA…. also works primarily where?
  • indications
  • SE
  • routes of admin
A

5-ASA within a protective coat
*mostly absorbed in SI

MOA:
1. exact MOA unknown

  1. anti-inflammatory + immunosuppressive properties effects via multiple mechanisms
    - ->inhibition of cytokine synthesis
    - ->inhibition of leukotriene and prostaglandin synthesis
    - ->scavenging of free radicals
    - ->inhibition of T-cell proliferation, activation and differentiation
    - ->impairment of leukocyte adhesion and function
  2. act locally in intestine

Indications: UC– both induction and maintenance of remission
*Mainstay for UC FIRST LINE **

SE:

  • less SE than Sulfasalazine
  • HA
  • dyspepsia

Routes of admin

  • PO
  • rectal–>FIRST LINE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pharmacokinetics for 5-ASA agents

  • incr and decr absoprtion with?
  • contraindicated with?
A

drugs increase absorption with more severe dz and has decreased absorption in decreasing pH evi (EX if PPI or H2 blocker also taken)

contra with sulfa allergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

SE for 5-ASA agents *mainly for Sulfasalazine

A

Blood dyscrasias– abnormalities in blood (anemia)

Nephrotoxicity

Hepatitis

SJS

Reversible male infertility

Inhibition of folate absorption

17
Q

what happens if you take a PPI, H2 rec antag and/or antacid with a 5-ASA agent ?

A

may increase systemic absoprtion and premature release of 5-ASA b4 reaching the site of action

*these drugs are pH dep

18
Q

Corticosteroids w/ IBD mainly used for?

*what to avoid with corticosteroid use?

A

INDUCING remission

avoid longterm use can cause cushing’s dz

19
Q

which form of corticosteroids have less SE

A

rectal

  • foams
  • enema
20
Q

pros and cons of rectcal corticoids for tx of IBD

A

PROS: less SE than systemic agents
CONS: limited to left-sided dz of UC

21
Q

Budesonide forms for IBD

A

PO

rectal

22
Q

Hydrocortisone forms for IBD

A

PO
IV
Rectal

23
Q

Methylprednisolone routes for IBD

A

PO

IV

24
Q

list the corticosteroids used for tx of IBD

A

Budesonide
Hydrocortisone
Prednisone
Methylprednisolone

25
Q

List the three biologic agents for IBD

A
  1. Tumor Necrosis Factor inhibitors (Infliximab, Adalimumab, Certolizumab, Golimumab)
  2. Alpha-4 integrin inhibitors–Vedolizumab
  3. IL-12/23 Inhibitors (Ustekinaumab)
26
Q

TNF-necrosis factors

  • MOA
  • INDS
  • Contras
A

MOA:

  • monoclonal antibodies directed against TNF-alpha
  • TNF-alpha has several biologic activities that may be directly related to the pathogenesis of IBD

INDS

  • induction and maintenance of remission for IBD
  • usually second line agent for IBD who have failed 5-ASA, unresponsive to or dependent on corticoids or who present with more severe dz

Contra:

  • active infection
  • latent or untx TB
  • demyelinating dz (MS or optic neuritis)
  • HF
27
Q

use of biologics is associated with?

A

increase risk for infections

28
Q

what should be done before a PT is placed on biologic agent tx?

A

evaluated for TB

29
Q
Alpha-Integrin Inhibitors 
MOA 
Pros to these agents 
INDs
SE
A

MOA: alpha-4 integrin inhibitors are monoclonal antibodies developed as gut-selective anti-integrin
*reduces leukocytes to the site of inflammation

Limited systemic immunosuppression-effect on GI tract

INDS:

  • moderate to severe CD and UC
  • refractory to TNF-alpha inhibitors

SE

  • HA
  • Arthralgia
  • Nausea
  • fatigue
  • MSK pain
30
Q

what are integrins

A

proteins involved in leukocyte migration to the gut

31
Q
Ustekinaumab
*class
*MOA 
*INDS
SE
A

IL-12/23 inhibitor

MOA: cytokine inhibitors
*inhibit cytokine IL-12 and IL-23– which are involved in lymphocyte activation aka the inflammatory process

INDS:
*induction and maint of remission of CD in PTS refractory to or intolerant of TNF-alpha inhibitors, immunomodulators or corticosteroids

SE

  • HA
  • arthralgia
  • Infection
  • nausea
  • nasopharyngitis
32
Q

which drug can cause nasopharyngitis

A

Ustekinaumab—- IL-12/23 inhibitor

33
Q

List the immunomodulators

A

Methotrexate

Thiopurines

34
Q

Methotrexate

  • class of drugs
  • MOA
  • OOA
  • Absoprtion
  • metabolism
  • SE
  • contra
  • routes of admin
  • INDS
A

Immunomodulator

  • folic acid antagonist–inhibits DNA synthesis, repair and cellular replication– esp targeting actively proliferating tissues (esp psoriasis)
  • folate helps with DNA synthesis

MOA: inhibits cytokine production and purine nucleotide biosynthesis–>leads to immunosuppresive and anti-inflammatory effects

OOA: 3-6 weeks (for tx of RA)

*abs is variable and is decreased at higher doses—likely due to saturation

Metabolism: partially metabolized by intestinal flora

SE:

  • *Many serious SE
  • ->mucosal ulceration
  • ->nausea
  • ->Cytopenias (esp leukopenia)
  • ->liver cirrhosis
  • ->acute pneumonia-like syndrome
  • ->HA
  • ->Vomiting
  • ->abdominal discomfort
  • ->serum aminotransferase elevations
  • ->rash
  • ->tumor lysis syndrome
  • ->Malignant lymphomas
  • *BB warning
  • *

CONTRA IN PREGNANCY**

  • IM or SC
  • admin with folic acid supplement to reduce the incidence of GI adverse effects

Indications:
*maintenance of remission in CD— NOT FOR UC

35
Q

what tests should be done on PTs being treated with Methotrexate

A

LFTs
CBC
monitoring for signs of infection

36
Q

Azathioprine and Mercaptopurine

  • class of drug
  • inds
  • OOA
  • drug interactions
  • SE
  • monitor PT for?
  • special note about Azathioprine
  • routes of admin
A

Thiopurines

MOA: exert a glucocorticoid-sparing effect for IBD (both UC and CD)

INDs:
*for PTs who cannot maintain remission when glucocorticoids are withdrawn

OOA: slow acting–3 or more months*****

Drug interactions: allopurinol and Febuxostat (slows elimination of 6-MP)

SE

  • Nausea
  • anorexia
  • vomiting
  • bone suppression
  • hepatoxicity

Monitor PT for cytopenias (CBCs) and transaminitis (elevation of liver enzymes)

Azathiopurine–prodrug
*converted to 6-MP by compounds found in tissues and RBCs–>metabolized by the liver and gut –>induce immunosuppression by inhibiting protein and purine synthesis in lymphocytes

PO only